Press release Oncology Venture to test activity of its PARP inhibitor, 2X-121, as a potential therapy for Coronavirus

Joey Cohen
Medication Adherence

Amy Giles
Increasing Engagement

David Linetsky
Point-of-Care Marketing

Stacey Gandler
Brand Nourishment

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs

Paul Theisen
Patient Acquisition

Liz Kane
Impactful Strategy

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

Pat Purcell
Meeting Engagement